(旧版)前立腺癌診療ガイドライン 2006年版
第7章 待機療法
参考文献
1) | Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347(11):781-9. |
2) | Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352(19):1977-84. |
3) | Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330(4):242-8. |
4) | Carter CA, Donahue T, Sun L, et al. Temporarily deferred therapy(watchful waiting)for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. J Clin Oncol. 2003;21(21):4001-8. |
5) | Choo R, Klotz L, Danjoux C, et al. Feasibility study:watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol. 2002;167(4):1664-9. |
6) | Cooperberg MR, Broering JM, Litwin MS, et al. The contemporary management of prostate cancer in the United States:lessons from the cancer of the prostate strategic urologic research endeavor(CapSURE), a national disease registry. J Urol. 2004;171(4):1393-401. |
7) | Bacon CG, Giovannucci E, Testa M, et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol. 2001;166(5):1804-10. |
8) | George N. Therapeutic dilemmas in prostate cancer:justification for watchful waiting. Eur Urol. 1998;34 Suppl 3:33-6. |
9) | Kakehi Y. Watchful waiting as a treatment option for localized prostate cancer in the PSA era. Jpn J Clin Oncol. 2003;33(1):1-5. |